Related references
Note: Only part of the references are listed.Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice
Ashfaq Ahmad et al.
MOLECULAR NEUROBIOLOGY (2017)
Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
Li Du et al.
MOLECULAR NEUROBIOLOGY (2017)
Neuroprotective Effect of Nanodiamond in Alzheimer's Disease Rat Model: a Pivotal Role for Modulating NF-κB and STAT3 Signaling
Shawqi H. Alawdi et al.
MOLECULAR NEUROBIOLOGY (2017)
Inflammatory mechanisms linking obesity and metabolic disease
Alan R. Saltiel et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Stressed and Inflamed, Can GSK3 Be Blamed?
Richard S. Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Obesity and diabetes: An update
Shalini Verma et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
Up-regulation of SIRT6 in the hippocampus induced rats with depression-like behavior via the block Akt/GSK3β signaling pathway
Qiang Mao et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Treatment of CIA Mice with FGF21 Down-regulates TH17-IL-17 Axis
Si-ming Li et al.
INFLAMMATION (2016)
Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed mice
Hwajin Kim et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies
Emilio Pedditizi et al.
AGE AND AGEING (2016)
Dietary obesity reversibly induces synaptic stripping by microglia and impairs hippocampal plasticity
Shuai Hao et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?
Taher Mandviwala et al.
CURRENT ATHEROSCLEROSIS REPORTS (2016)
FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats
Piangkwan Sa-nguanmoo et al.
HORMONES AND BEHAVIOR (2016)
Increased risk of cognitive impairment in patients with components of metabolic syndrome
Chia-Kuang Tsai et al.
MEDICINE (2016)
Potential roles of fibroblast growth factor 21 in the brain
Piangkwan Sa-nguanmoo et al.
METABOLIC BRAIN DISEASE (2016)
Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury
Yoon Kyung Choi et al.
NATURE MEDICINE (2016)
Exercise prevents high-fat diet-induced impairment of flexible memory expression in the water maze and modulates adult hippocampal neurogenesis in mice
C. Klein et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2016)
Time-dependent behavioral, neurochemical, and metabolic dysregulation in female C57BL/6 mice caused by chronic high-fat diet intake
Saritha Krishna et al.
PHYSIOLOGY & BEHAVIOR (2016)
Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis
Kathleen R. Markan et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Fibroblast Growth Factor Signaling in Metabolic Regulation
Vera J. M. Nies et al.
FRONTIERS IN ENDOCRINOLOGY (2016)
Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas
Garima Singhal et al.
PLOS ONE (2016)
High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice
Roel A. van der Heijden et al.
AGING-US (2015)
FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism
Yusuke Joki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Adult Hippocampal Neurogenesis, Aging and Neurodegenerative Diseases: Possible Strategies to Prevent Cognitive Impairment
Carmen Vivar
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
The role of fibroblast growth factor 21 in diabetes and its complications: A review from clinical perspective
Jian-Jun Liu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models
Erika Calvo-Ochoa et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
Effects of fibroblast growth factor 21 on the heart
Pongpan Tanajak et al.
JOURNAL OF ENDOCRINOLOGY (2015)
FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs
Kook Hwan Kim et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Fibroblast growth factor-21, energy balance and obesity
Marta Giralt et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
MODELS AND MECHANISMS FOR HIPPOCAMPAL DYSFUNCTION IN OBESITY AND DIABETES
A. M. Stranahan
NEUROSCIENCE (2015)
Fibroblast growth factor 21 protects mouse brain against D-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation
Yinhang Yu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties
Alexei Kharitonenkov et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity
Nathalie Castanon et al.
FRONTIERS IN NEUROSCIENCE (2015)
FGF21 and cardiac physiopathology
Anna Planavila et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Fibroblast growth factor 21 analogs for treating metabolic disorders
Jun Zhang et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Fibroblast growth factor 21 protects the heart from oxidative stress
Anna Planavila et al.
CARDIOVASCULAR RESEARCH (2015)
Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies
Kay Deckers et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Functions and Dysfunctions of Adult Hippocampal Neurogenesis
Kimberly M. Christian et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 37 (2014)
Obesity and neuroinflammation: A pathway to cognitive impairment
Alyson A. Miller et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: Focus on brain indoleamine 2,3-dioxygenase activation
Caroline Andre et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
The Negative Effects of Obesity and Poor Glycemic Control on Cognitive Function: A Proposed Model for Possible Mechanisms
Michael L. Alosco et al.
CURRENT DIABETES REPORTS (2014)
FGF21 Maintains Glucose Homeostasis by Mediating the Cross Talk Between Liver and Brain During Prolonged Fasting
Qingning Liang et al.
DIABETES (2014)
Obesity Elicits Interleukin 1-Mediated Deficits in Hippocampal Synaptic Plasticity
Joanna R. Erion et al.
JOURNAL OF NEUROSCIENCE (2014)
Amelioration of Diabetes-induced Cognitive Deficits by GSK-3β Inhibition is Attributed to Modulation of Neurotransmitters and Neuroinflammation
Ashok Kumar Datusalia et al.
MOLECULAR NEUROBIOLOGY (2014)
High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice
Steven E. Arnold et al.
NEUROBIOLOGY OF DISEASE (2014)
FGF Receptors: Cancer Biology and Therapeutics
Masaru Katoh et al.
MEDICINAL RESEARCH REVIEWS (2014)
FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
Kook Hwan Kim et al.
DIABETES & METABOLISM JOURNAL (2014)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives
Y. C. Woo et al.
CLINICAL ENDOCRINOLOGY (2013)
Exercise reduces activation of microglia isolated from hippocampus and brain of aged mice
Rachel A. Kohman et al.
JOURNAL OF NEUROINFLAMMATION (2013)
FGF21 regulates metabolism and circadian behavior by acting on the nervous system
Angie L. Bookout et al.
NATURE MEDICINE (2013)
Neuroinflammation and neurodegeneration in overnutrition-induced diseases
Dongsheng Cai
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Dyslipidemia in Obesity: Mechanisms and Potential Targets
Boudewijn Klop et al.
NUTRIENTS (2013)
Long-Acting FGF21 Has Enhanced Efficacy in Diet-Induced Obese Mice and in Obese Rhesus Monkeys
Murielle M. Veniant et al.
ENDOCRINOLOGY (2012)
Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance
Clarence Hale et al.
ENDOCRINOLOGY (2012)
Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
Pedro Iglesias et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Metabolic Syndrome, Mild Cognitive Impairment and Dementia
F. Panza et al.
CURRENT ALZHEIMER RESEARCH (2011)
Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid Relationship With Plasma FGF21 and Body Adiposity
Bee K. Tan et al.
DIABETES (2011)
Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress
Sudarshana Purkayastha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
FGF21 as an Endocrine Regulator in LipidMetabolism: From Molecular Evolution to Physiology and Pathophysiology
Yusuke Murata et al.
JOURNAL OF NUTRITION AND METABOLISM (2011)
High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli
Huiyan Wang et al.
BMC BIOTECHNOLOGY (2010)
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Ffolliott M. Fisher et al.
DIABETES (2010)
Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet
V. A. Gault et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms
Francesco Panza et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Is Insulin Resistant Brain State a Central Feature of the Metabolic-Cognitive Syndrome?
Vincenza Frisardi et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
Klementina Fon Tacer et al.
MOLECULAR ENDOCRINOLOGY (2010)
A high-fat diet impairs neurogenesis: Involvement of lipid peroxidation and brain-derived neurotrophic factor
Hee Ra Park et al.
NEUROSCIENCE LETTERS (2010)
Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models-association with liver and adipose tissue effects
Jing Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Impairments in glucose tolerance can have a negative impact on cognitive function: A systematic research review
Daniel J. Lamport et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c
Masashi Suzuki et al.
MOLECULAR ENDOCRINOLOGY (2008)
A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
Li Liu et al.
Jove-Journal of Visualized Experiments (2008)
The fasting polypeptide FGF21 can enter brain from blood
Hung Hsuchou et al.
PEPTIDES (2007)
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Alexei Kharitonenkov et al.
ENDOCRINOLOGY (2007)
High-fat diets: Modeling the metabolic disorders of human obesity in rodents
Roland Buettner et al.
OBESITY (2007)
Share Paper
